INDICATION AND IMPORTANT SAFETY INFORMATION
Trianex® 0.05% (Triamcinolone Acetonide Ointment, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The most common adverse events with Trianex Ointment include burning, itching, irritation, dryness, and folliculitis. Trianex Ointment is contraindicated in patients who are hypersensitive to any of the ingredients of this product. As with all topical corticosteroids, systemic absorption can produce reversible HPA-axis suppression.
Trianex is a registered trademark of CMP Pharma, Inc. ©2015 Promius Pharma, LLC. All rights reserved.